Brazilian Regulatory Authority Continues To Approve Covid-19 Vaccine Trials
Pharma & Healthcare / Brazil / Fri 10 Jul, 2020
Key View
- The Brazilian National Regulatory Agency continues to approve vaccine trials in the country to tackle the Covid-19 pandemic.
- Further partnerships between Brazil and international vaccine developers likely to take place in H220 due to the country’s high daily case count.
- Discordant government response continues to be detrimental to